Bessemer Venture Partners and International Finance Corporation planning to exit NephroPlus completely by divesting about 30 per cent stake together
Read More
The agreements effectively resolve all pending claims filed against the company for failing to warn patients about the risk of contracting chronic kidney disease and related issues
Read More
According to the statement, IQuest emerged as the preferred investor for the API division of Viatris after a worldwide competitive bidding process.
Read More
The company said the funds from this round will be used to further enhance the AI motion coach, making it available in local languages, and expanding the platform's reach in the MENA and North American regions
Read More
Driven solely by the mission to transform healthcare professional (HCP) marketing globally, the funds will enable Doceree to accelerate product development, augment technologies, scale global expansion, and expand its team
Read More
Bain capital backed Emcure Pharma aims to raise 400-500billion dollars through IPO, reviving it’s listing plans which it had postponed earlier in 2022 due to global market disturbance caused by Ukraine -Russia conflict
Read More
Glenmark Pharmaceuticals on Thursday said that it has entered into a definitive agreement with Nirma to divest 75 per cent stake in its subsidiary, Glenmark Life Sciences (GLS), at a price of Rs 615 per share for an aggregate consideration of Rs 5,651.5 crores
Read More
QubeHealth, a healthcare payments company has topped-up its Pre-Series-A round with investments led by the Inflection Point Ventures, Green Ivy Ventures and other Family Investment offices
Read More
